Genetic background for immune-mediated diseases

By Vartdal Frode  

Acta Odontologica Scandinavica, Vol. 59, Iss. 4, 2001-08 ,pp. : 212-215

Informa Healthcare

Access to resources Recommend Favorite

Editorial: Immune-mediated mucosal diseases: tales about battles lost and won

By Schenck Karl   Kiyono Hiroshi   Helgeland Kristen   Steinsvoll Svein   Taylor Barbara  

Acta Odontologica Scandinavica, Vol. 59, Iss. 4, 2001-08 ,pp. : 209-211

Informa Healthcare

Access to resources Recommend Favorite

Homeobox protein MSX‐1 inhibits expression of bone morphogenetic protein 2, bone morphogenetic protein 4, and lymphoid enhancer‐binding factor 1 via Wnt/β‐catenin signaling to prevent differentiation of dental mesenchymal cells during the late bell stage

By  

European Journal of Oral Sciences, Vol. 126, Iss. 1, 2018-02 ,pp. : 1-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone powder enhances the effectiveness of bioactive glass S53P4 against strains of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in suspension

By Waltimo Tuomas   Zehnder Matthias   Söderling Eva  

Acta Odontologica Scandinavica, Vol. 64, Iss. 3, 2006-06 ,pp. : 183-186

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the osteoconductive properties of three particulate bone fillers in a rabbit model: Allograft, calcium carbonate (Biocoral®) and S53P4 bioactive glass

By Gunn Jarmo M.   Rekola Jami   Hirvonen Jussi   Aho Allan J.  

Acta Odontologica Scandinavica, Vol. 71, Iss. 5, 2013-09 ,pp. : 1238-1242

Informa Healthcare

Access to resources Recommend Favorite